Epithelioid sarcoma other diagnostic studies: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 14: Line 14:
==Reference==
==Reference==
{{Reflist|2}}
{{Reflist|2}}
[[Category:Dermatology]]
[[Category:Disease]]
[[Category:Types of cancer]]

Revision as of 16:54, 22 February 2016

Epithelioid sarcoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Epithelioid sarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

MRI

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Epithelioid sarcoma other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Epithelioid sarcoma other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Epithelioid sarcoma other diagnostic studies

CDC on Epithelioid sarcoma other diagnostic studies

Epithelioid sarcoma other diagnostic studies in the news

Blogs on Epithelioid sarcoma other diagnostic studies

Directions to Hospitals Treating Epithelioid sarcoma

Risk calculators and risk factors for Epithelioid sarcoma other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

Other diagnostic studies for epithelioid sarcoma include genetic testing and immunohistochemistry.

Genetic Testing

  • Loss of INI1 (also known as hSNF5 and SMARCB1) which is a member of SWI/SNF multi-subunit chromatin remodeling complex located on the long arm of chromosome 22 (22q11.2) has been a diagnostic modality of epithelioid sarcoma.
  • Immunohistochemical staining of INI1 is available and can be used for the diagnosis of epithelioid sarcoma. MRI is the diagnostic modality of choice for imaging prior to biopsy and pathologic diagnosis, with the primary role being the determination of anatomic boundaries.

Immunohistochemistry

  • Immunohistochemical staining of INI1 is available and can be used for the diagnosis of epithelioid sarcoma.
  • Vimentin reactivity
  • Pankeratin AE1/AE3 and epithelial membrane antigen
  • Negative S100

Reference